Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines. 1997

T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
Pediatric Allergy and Infectious Diseases Society of Sapporo, Japan.

BACKGROUND This study was designed to investigate the development of both cellular and humoral immune responses to gelatin in patients with vaccine-related immediate and nonimmediate reactions. Our purpose was to define the nature of the responses in the different clinical states. METHODS Six patients with immediate reactions and 21 patients with nonimmediate reactions after inoculation of various live vaccines were studied. Measurement of gelatin-specific IgE was performed in all subjects. Gelatin-specific T-cell responses detected by an in vitro lymphocyte proliferation assay and by an assay for IL-2 responsiveness were investigated to compare the immune response in patients with the two types of reaction. RESULTS All six patients with immediate reactions had IgE responses to gelatin, whereas none of the 21 patients with nonimmediate reactions had any anti-gelatin IgE. All of the six patients with immediate reactions and 17 of the 21 patients with nonimmediate reactions exhibited positive T-lymphocyte responses specific to gelatin. CONCLUSIONS Immediate and nonimmediate reactions are caused by different types of allergy to gelatin, and cell-mediated immunity to gelatin may play an important role in the pathogenesis of nonimmediate reactions.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007223 Infant A child between 1 and 23 months of age. Infants
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D009108 Mumps Vaccine Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. Inactivated Mumps Vaccine,Inactivated Mumps Virus Vaccine,Live Attenuated Mumps Vaccine,Live Attenuated Mumps Virus Vaccine,Mumps Vaccine, Inactivated,Mumps Vaccine, Live Attenuated,Mumps Virus Vaccine, Inactivated,Mumps Virus Vaccine, Live Attenuated,Vaccine, Inactivated Mumps,Vaccine, Mumps
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
October 1995, The Journal of allergy and clinical immunology,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
April 2020, The Cochrane database of systematic reviews,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
November 2021, The Cochrane database of systematic reviews,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
July 2006, Jornal de pediatria,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
March 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
November 1974, The Journal of infectious diseases,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
March 1969, JAMA,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
May 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
May 2009, Vaccine,
T Kumagai, and T Yamanaka, and Y Wataya, and A Umetsu, and N Kawamura, and K Ikeda, and H Furukawa, and K Kimura, and S Chiba, and S Saito, and N Sugawara, and F Kurimoto, and M Sakaguchi, and S Inouye
July 1975, Wisconsin medical journal,
Copied contents to your clipboard!